Literature DB >> 1566748

Mu-heavy chain disease: presentation as a benign monoclonal gammopathy.

D L Wahner-Roedler1, R A Kyle.   

Abstract

mu-Heavy chain disease (HCD) is a rare monoclonal lymphoid disorder characterized by the failure to assemble a complete IgM immunoglobulin. The mu-heavy chains analyzed to date revealed absence of the variable region and a shortened constant domain. We report the first case of mu-HCD presenting as a benign monoclonal gammopathy. The literature on the 27 reported mu-HCD cases is reviewed, and important clinical and laboratory findings are discussed. The ages of the patients ranged from 15 to 80 years (median, 57.5 years). Twenty-two of 27 patients had an associated lymphoplasma cell proliferative disorder. A monoclonal spike on routine serum protein electrophoresis was found in only 8 of 19 patients. Fourteen of 22 patients had Bence Jones proteinuria, but mu-HCD protein was reported in the urine of only two patients. The survival ranged from less than 1 month to 11 years (median, 24 months).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1566748     DOI: 10.1002/ajh.2830400112

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  9 in total

1.  Multiple extranodal tumors in mu-heavy chain disease.

Authors:  Akinori Maeda; Minako Mori; Satoko Torii; Yuya Nagai; Katsuhiro Togami; Haruyuki Fujita; Masayuki Kurata; Akiko Matsushita; Kenichi Nagai; Yukihiro Imai; Takayuki Takahashi
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

Review 2.  Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments.

Authors:  Mehdi Arbabi-Ghahroudi
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

Review 3.  Successful treatment of mu-heavy chain disease with fludarabine monophosphate: a case report.

Authors:  Machi Yanai; Akinori Maeda; Naoko Watanabe; Naoshi Sugimoto; Akiko Matsushita; Kenichi Nagai; Tatsuo Oida; Takayuki Takahashi
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

Review 4.  Heavy chain disease.

Authors:  Thomas E Witzig; Dietlind L Wahner-Roedler
Journal:  Curr Treat Options Oncol       Date:  2002-06

Review 5.  Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update.

Authors:  Roberto Ria; Franco Dammacco; Angelo Vacca
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-01-01       Impact factor: 2.576

6.  Gamma-heavy chain monoclonal gammopathy with undetermined significance (MGUS).

Authors:  Yuriko Zushi; Miho Sasaki; Toshiharu Saitoh; Yumi Aoyama; Yuta Gotoh; Hiroko Tsunemine; Taiichi Kodaka; Atsuo Okamura; Takayuki Takahashi
Journal:  J Clin Exp Hematop       Date:  2019-08-08

7.  Novel Possible Protein Targets in Neovascular Age-Related Macular Degeneration: A Pilot Study Experiment.

Authors:  Bruno Nobre Lins Coronado; Felipe Bruno Santos da Cunha; Raphaela Menezes de Oliveira; Otávio de Toledo Nóbrega; Carlos André Ornelas Ricart; Wagner Fontes; Marcelo Valle de Sousa; Marcos Pereira de Ávila; Aline Maria Araújo Martins
Journal:  Front Med (Lausanne)       Date:  2022-01-27

8.  Light chain proteinuria revealing mu-heavy chain disease: an atypical presentation of Waldenström macroglobulinemia in two cases.

Authors:  Hélène Vergneault; Djaouida Bengoufa; Aline Frazier-Mironer; Isabelle Brocheriou; Samuel Bitoun; Camille Villesuzanne; Alexis Talbot; Stéphanie Harel; Bertrand Arnulf; Bruno Royer
Journal:  Haematologica       Date:  2021-07-01       Impact factor: 9.941

9.  Two Cases of Heavy Chain MGUS.

Authors:  Jan Van Keer; Björn Meijers; Michel Delforge; Gregor Verhoef; Koen Poesen
Journal:  Case Rep Oncol Med       Date:  2016-04-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.